Thomas M Polasek
18PUBLICATIONS
44CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (18)
Sort by Publication Date:
|Dec 22, 2025
Reply to "Minor Contribution of UGT1A1 Inhibition to Atazanavir-Related Bilirubin Elevation Supported by Conservative PBPK Modeling and Clinical Data".John O Miners, Thomas M Polasek
|Jun 26, 2025
Using pharmacogenomics to personalise drug therapy: which drugs, when and how.Sophie L Stocker, Thomas M Polasek
|May 26, 2025
Caution with PBPK Modeling Based on the In Vitro Kinetics for Bilirubin Hepatic Uptake and Glucuronidation: Commentary on Dong et al.John O Miners, Thomas M Polasek
|Dec 10, 2024
Static Versus Dynamic Model Predictions of Competitive Inhibitory Metabolic Drug-Drug Interactions via Cytochromes P450: One Step Forward and Two Steps Backwards.Ivan Tiryannik, Aki T Heikkinen, Iain Gardner
|Aug 01, 2024
Recent Advances Addressing the Challenges of Precision Dosing.Iris K Minichmayr, Tomoyuki Mizuno, Srijib Goswami
Pageof 3
Frequent Collaborators
4 joint publications
Amin Rostami-Hodjegan
3 joint publications
Sam Mostafa
3 joint publications
Chad Bousman
3 joint publications
Carl Mj Kirkpatrick
2 joint publications
Andrew Rowland
2 joint publications
John O Miners
2 joint publications
Richard W Peck
1 joint publications
Vidya Perera
1 joint publications
Emily Mannix
1 joint publications
Sebastian Levesque